Cancer Stem Cell Markers and Related Network Pathways
Published on 3. January 2023
Book
Hardback
XIV, 156 pages
978-3-031-12973-5 (ISBN)
Description
This book entitled "Cancer Stem Cell Markers and Related Network Path-ways" is about cancer stem cell (CSC) markers and the molecular network pathways. CSCs play an important role in the cancer drug resistance, metastasis and recurrence. Epithelial-mesenchymal transition (EMT) is closely related to CSC phenotype.
This book covers various aspects of the molecular networks related to CSCs including the important phenotypic change such as EMT. Readers will discover the importance of the identification of CSC markers and EMT-related molecules in CSC network pathways.
The CSC signaling pathways and EMT molecular network pathways attract researchers in the field to define the cancer therapeutic targets. Cancer environment is important in the acquisition of CSC phenotype in cells. The revealing of this CSC mystery is across 7 chapters.
The topic of this book is particularly relevant to research in thefield of cancer and stem cells, as well as the network pathways. We hope that this book helps the readers to be interested in understanding why the CSC concept is important and attractive.
This book covers various aspects of the molecular networks related to CSCs including the important phenotypic change such as EMT. Readers will discover the importance of the identification of CSC markers and EMT-related molecules in CSC network pathways.
The CSC signaling pathways and EMT molecular network pathways attract researchers in the field to define the cancer therapeutic targets. Cancer environment is important in the acquisition of CSC phenotype in cells. The revealing of this CSC mystery is across 7 chapters.
The topic of this book is particularly relevant to research in thefield of cancer and stem cells, as well as the network pathways. We hope that this book helps the readers to be interested in understanding why the CSC concept is important and attractive.
More details
Series
Edition
1st ed. 2022
Language
English
Place of publication
Cham
Switzerland
Publishing group
Springer International Publishing
Target group
Professional and scholarly
Illustrations
21 farbige Abbildungen, 2 s/w Abbildungen
XIV, 156 p. 23 illus., 21 illus. in color.
Dimensions
Height: 260 mm
Width: 183 mm
Thickness: 15 mm
Weight
572 gr
ISBN-13
978-3-031-12973-5 (9783031129735)
DOI
10.1007/978-3-031-12974-2
Schweitzer Classification
Other editions
Additional editions
Shihori Tanabe
Cancer Stem Cell Markers and Related Network Pathways
Book
01/2024
Springer
€139.09
Shipment within 15-20 days
Shihori Tanabe
Cancer Stem Cell Markers and Related Network Pathways
E-Book
01/2023
1st Edition
Springer
€128.39
Available for download
Person
Shihori Tanabe, Ph.D. has been working as a Senior Researcher at the Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences from April 2016. From Apr 2005 until Jan 2006 she held a position of a Post Doctoral Fellow at the Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo. From Feb 2006 until Mar 2010 she worked as a Researcher at the Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo Japan. She also had a position of a Senior Researcher at the Division of Safety Information on Drug, Food and Chemicals, National Institute of Health Sciences (Apr 2010 - Mar 2016, Tokyo Japan)
Content
1. Epithelial-mesenchymal transition and cancer stem cells.- 2. The transcription factors Zeb1 and Snail induce cell malignancy and can-cer stem cell phenotype in prostate cells, increasing androgen synthesis ca-pacity and therapy resistance.- 3. ERBB signaling pathway in cancer stem cells.- 4. Functional and molecular characters of cancer stem cells through devel-opment to establishment.- 5. Microenvironment in cancer stem cells.- 6. Cancer stem cells contribute to drug resistance in multiple different ways.- 7. Abnormal glycosylation in cancer cells and cancer stem cells as a thera-peutic target.